Vascular Endothelial Growth Factor Inhibitor Market

About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing the perfect solution for our client. Capabilities Sector Coverage Customized Syndicated Investment Social Media Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Customized Syndicated Investment Social Media Subscription Information For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com 2015 Future Market Insights, All Rights Reserved 2

Methodology (1/2) Systematic Approach Market profiling Formulating discussion guide Developing list of respondents Data collection Data validation 4 5 3 1 2 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. PMR formulates a detailed discussion guide to conduct expert and industry interviews PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts PMR conducts interviews with industry experts, industry players, distributors and retailers Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data Data Collection Data Filter & Analysis Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments A Primary C Company Analysis & Intelligence SOLUTION Actionable Insights B Desk Business Solution Key industry experts Channel study Developments Market dynamics Products Conclusions Data analysis 6 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry Primary # Secondary # Paid Publications# Insights 7 PMR delivers industry insights and information in the required format (PDF) Linkedin Zoominfo Salesforce Avention Company websites Company annual reports White papers Financial reports Factiva GBI Genios Meltwater # includes sources of databases 2015 Future Market Insights, All Rights Reserved 3

Vascular Endothelial Growth Factor (VEGF), is a process of formation of new blood vessels from endothelial cells or the pre-existing vessels. VEGF s normal function is during embryonic development, the formation of new blood vessels after injury, in muscle after exercise and as a bypass for a blocked vessel. Overexpression of VEGF can be fatal as they can grow into cancerous cells. VEGF plays both beneficial and damaging roles in organisms. VEGF takes circulating endothelial precursor cells and acts as a growth medium for immature tumor cells. The affinity of VEGF toward endothelial cells is mediated through VEGF-specific tyrosine-kinase receptor: VEGFR-1, VEGFR-2, and VEGFR-3. Hence VEGF and its receptors play a major role in the growth of tumor cells. The endotheliotropic property of VEGF causes a major concern for developing Vascular Endothelial Growth Factor Receptor Inhibitor. The VEGF family in mammals comprises of members VEGF-A, VEGF-B, VEGF-C, VEGF-D, and PIGF, out of these the VEGF-A is responsible for angiogenesis and migration and mitosis of endothelial cells. Many therapeutic strategies are developed for inhibiting the signal transduction of VEGF. Some of the therapeutic options are monoclonal antibodies against VEGF or VEGFR, soluble VEGF and VEGFR hybrids and tyrosine kinase inhibitors. Vascular Endothelial Growth Factor Inhibitor Market: Drivers and Restraints The global increase in the prevalence of cancer and recognition of therapeutic opportunities offered by oncology treatments have boosted pharmaceutical industry to develop new agents to treat cancer. 2015 Future Market Insights, All Rights Reserved 4

According to WHO, the new cancer cases are expected to rise by 70% in coming two decades. Approximately 60% of malignant tumors express high concentrations of VEGF, therapeutic option to inhibit the VEGF tumor causing pathway has become a major concern for all researchers. Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3292 Some of the restraining factors for VEGF inhibitor to be a silver bullet in the treatment of cancer is that angiogenesis is not the only factor causing a tumor. While the lesser known restraints are the side effects caused by VEGF inhibitors are bleeding and increased blood pressure Vascular Endothelial Growth Factor Inhibitor Market: Segmentation The Vascular Endothelial Growth Factor market is segmented according to the mode of action of the drug, route of administration, end users, and geography. The segmentation by mode of action of the drug is tyrosine kinase inhibitor: inhibits the adenosine triphosphate binding site, monoclonal antibody: they bind to VEGF-A preventing it from binding to receptors and activating the signaling cascades that lead to angiogenesis and vascular endothelial growth factor receptor hybrids: act as a decoy receptor and prevents binding of the ligand to its natural receptors. By route of administration, Africa. 2015 Future Market Insights, All Rights Reserved 5

it is segmented as oral and intravenous. By end user, the segmentation is classified as hospitals, ambulatory surgical centers, and cancer research institutes. Segmentation by Geography is North America, West Europe, APEJ, Japan, Eastern Europe, Latin America and the Middle East and Africa. Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3292 Vascular Endothelial Growth Factor Inhibitor Market: Overview Vascular Endothelial Growth Factor Inhibitors are also termed as Angiogenesis Inhibitor which inhibits the growth of the new blood vessels. Angiogenesis Inhibitors are effective in the treatment of cancer macular degeneration in the eye and diseases that involve proliferation of blood vessels. VEGF or angiogenesis is regulated by the activity of endogenous stimulators and inhibitors. Endogenous inhibitors are present in the body involved in regulating the process of blood vessel formation. Endogenous inhibitors are derived from the cellular matrix and basement protein. Among the factors responsible for angiogenesis, VEGF is the most potent and has high expression in ovarian, endometrial and cervical cancer. Inhibition of angiogenesis by VEGF requires anti VEGF / anti angiogenesis factors which reduce the production of pro angiogenic factor thereby preventing them from binding 2015 Future Market Insights, All Rights Reserved 6

to their receptors. The commonly used therapy for VEGF pathway inhibition is a monoclonal antibody against VEGF or VEGFR, soluble VEGFR hybrids, and tyrosine kinase inhibitors. Among this, the most widely used treatment is with monoclonal antibody Bevacizumab. Vascular Endothelial Growth Factor Inhibitor Market: Regional Overview The monoclonal antibody segment is growing faster in North America and Europe vascular endothelial growth factor inhibitor marketvascular endothelial growth factor inhibitor market. North America region accounts for the largest market share for tyrosine kinase inhibitor followed by Asia-Pacific and Europe. Vascular Endothelial Growth Factor Inhibitor Market: Key Players Some of the players in the market of Vascular Endothelial Growth Factor Inhibitor are Pfizer Inc., Novartis Pharmaceutical Corporation, AstraZeneca, Bayer Healthcare, Merck & Co. Inc., Genetech Inc., Eli Lilly, Sanofi Aventis, GlaxoSmithKline, Bristol-Myer Squibb and Boehringer Ingelheim 2015 Future Market Insights, All Rights Reserved 7

To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Harish Tiwari (General Manager & Global Head Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Thank You Future Market Insights Global & Consulting Private Limited (FMI) 2015 Future Market Insights, All Rights Reserved 8